Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity

Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, May 15, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing...

Related Keywords

Boston ,Massachusetts ,United States ,Atlanta ,Georgia ,Alex Lobo ,Miltonh Werner ,Facebook ,Nasdaq ,Office Of Cardiology ,Division Of Cardiology ,Sternir Inc ,Linkedin ,Company Contact ,Steam Review ,Exchange Commission ,Inhibikase Or Company ,Division Of Hematologic Malignancies ,Youtube ,Inhibikase Therapeutics Inc ,Abelson Tyrosine Kinases ,Chief Executive Officer ,Upcoming Milestones ,Meeting Minutes ,Hematologic Malignancies ,Review Team ,Pulmonary Arterial Hypertension ,Final Meeting Minutes ,Abelson Tyrosine Kinase ,Abelson Tyrosine ,Multiple System Atrophy ,Private Securities Litigation Reform Act ,Consolidated Statements ,Comprehensive Loss ,Months Ended March ,